Obinutuzumab Beta Combined With Low-dose Glucocorticoid in New-onset ANCA-Associated Glomerulonephritis

NCT07746180 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

ANCA-Associated Glomerulonephritis (AAGN)
ANCA-Associated Vasculitis (AAV)

Interventions

DRUG: Obinutuzumab beta
DRUG: Glucocorticoids

Sponsor

Chinese PLA General Hospital